Business Segment and Geographical Information

9 Months Ended

Oct. 02, 2021

Segment Reporting [Abstract]

Business Segment and Geographical Information [Text Block]

Note 4.    Business Segment and Geographical Information

Business Segment Information

	Three Months Ended				Nine Months Ended
	October 2,		September 26,		October 2,		September 26,
(In millions)	2021		2020		2021		2020
Revenues
Life Sciences Solutions	$	3,721	$	3,424	$	11,481	$	7,800
Analytical Instruments	1,476		1,336		4,344		3,488
Specialty Diagnostics	1,362		1,430		4,212		3,376
Laboratory Products and Services	3,487		3,112		10,667		8,629
Eliminations	(716)		(781)		(2,195)		(1,625)
Consolidated revenues	9,330		8,521		28,509		21,668
Segment Income
Life Sciences Solutions	1,821		1,879		5,818		3,788
Analytical Instruments	264		171		816		477
Specialty Diagnostics	310		398		983		848
Laboratory Products and Services	383		355		1,360		931
Subtotal reportable segments	2,778		2,803		8,977		6,044
Cost of revenues charges	—		(1)		(8)		(5)
Selling, general and administrative (charges) credits	(59)		55		(33)		7
Restructuring and other costs	(18)		(17)		(151)		(67)
Amortization of acquisition-related intangible assets	(423)		(414)		(1,295)		(1,256)
Consolidated operating income	2,278		2,426		7,490		4,723
Interest income	9		9		32		53
Interest expense	(128)		(144)		(375)		(407)
Other income (expense)	14		(39)		(174)		(36)
Income before income taxes	$	2,173	$	2,252	$	6,973	$	4,333

Geographical Information

	Three Months Ended				Nine Months Ended
	October 2,		September 26,		October 2,		September 26,
(In millions)	2021		2020		2021		2020
Revenues (a)
United States	$	4,495	$	4,428	$	13,742	$	10,981
China	885		828		2,454		1,886
Other	3,950		3,265		12,313		8,801
Consolidated revenues	$	9,330	$	8,521	$	28,509	$	21,668

(a)     Revenues are attributed to countries based on customer location.